跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Butyramide
首页
药物
Butyramide
Experimental
Small Molecule
Butyramide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
4
H
9
NO
CAS 编号
541-35-5
UNII ID
9J6OR937VR
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
2-adamantyl-butyramide derivatives as selective 11-HSD1 inhibitors
US 8183265 B2
申请人: ROCHE DIDIER
优先权: 2006
EP
US
3 件公开
N-BUTYRAMIDE, THE PREPARATION METHOD AND USE THEREOF
US 2011190495 A1
申请人: TOPHARMAN SHANGHAI CO LTD
优先权: 2007
US
2 件公开
Preparation method of aztreonam intermediate (3S-trans)-3-amido-4-methyl-2-oxo-1-sulfoazetidine
CN 100586930 C
申请人: CHONGQING LUMMY PHARMACEUTICAL
优先权: 2008
CN
2 件公开
2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
US 8586748 B2
申请人: ABEYWARDANE ASITHA
优先权: 2009
US
2 件公开
Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
US 2010286138 A1
申请人: LUNDBECK & CO AS H
优先权: 2010
US
2 件公开
CN 102459208 A
申请人: LUNDBECK & CO AS H
优先权: 2010
CN
Methods for enhanced bioavailability and open exposure of voltage gated potassium ion channels
CN 120549929 A
申请人: XENON PHARMACEUTICALS INC
优先权: 2018
CN
2 件公开
Homoserine lactone compound for effectively inhibiting formation of multi-drug-resistant pseudomonas aeruginosa biofilm
CN 119912411 A
申请人: UNIV LANZHOU
优先权: 2025
CN
2 件公开
5-trityloxymethyl-oxazolidinones and process for the preparation thereof
US 6288239 B1
申请人: UNIV MICHIGAN STATE
优先权: 2000
US
Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity
US 2006287397 A1
申请人: MEZA TOLEDO SERGIO E
优先权: 2002
US
Processes for the Preparation of Zolpidem and its Hemitartrate
US 2008262025 A1
申请人: KUMAR YATENDRA
优先权: 2004
US
第 1 / 6 页
上一页
下一页
药物
反馈